Objective-To see whether zinc supplementation during pregnancy improves maternal and fetal outcome.
Introduction
Zinc is an essential trace element in many metabolic pathways.' Frank zinc deficiency induced in laboratory animals is associated with reduced fertility, fetal neurological malformations, and growth retardation in late pregnancy.' In human pregnancies, however, the picture is more complex. Pregnancies occurring in women with acrodermatitis enteropathica are subject to congenital malformations and increased losses.4 In otherwise normal women low maternal plasma or serum zinc concentrations have been reported to be associated with abnormalities of labour, atonic bleeding, congenital malformations, preterm labour, and post-term pregnancies. There are also reports of low plasma zinc values in women who developed hypertension in pregnancy.6' Prema"' and Ghosh et al,"
however, were unable to predict any abnormal outcome of pregnancy on the basis of serum zinic concentrations.
The relation between maternal zinc concentrations and birth weight is also inconsistent. Prasad et al' and Atinmo et al"' found a positive correlation but this was not confirmed by others,'4'6 and several workers have even noted an inverse relation between fetal size and maternal plasma zinc value.,-"
These inconsistent findings may be related to the insensitivity of plasma zinc as an indicator of zinc state.'" Jones et al found a close correlation between concentrations of zinc in leucocytes and muscle'" but not between plasma zinc and either muscle zinc or leucocyte zinc concentrations2; as skeletal muscle contains a large proportion of body zinc, they suggested that the leucocyte zinc concentration might be the more useful indicator oftissue state. A direct correlation has been found between fetal growth retardation and maternal leucocyte zinc concentration" '-but not maternal plasma zinc value.2' Simmer and Thompson showed a relation between intrauterine growth retardation and postnatal polymorphonuclear leucocyte zinc concentration as a measure of zinc state.2 ' The suggested associations between maternal zinc depletion and poor outcome of pregnancy raise the possibility of prevention by using supplementary zinc. The efficacy of such a strategy has yet to be fully assessed. This The mothers were advised to take one capsule daily after breakfast. Serum haemoglobin and ferritin concentrations were measured in all women at the first visit. Iron and folate supplementation was advised only if the haemoglobin concentration was less than 100 g/l An information sheet was posted to the mother's general practitioner explaining the study as well as the need to avoid giving routine iron and folate supplementation. General practitioners, however, were free to give supplements if that was their routine practice. If supplements were prescribed patients were advised to take the iron and folate tablet in the evening and to avoid taking the iron and study capsules together.
Enough capsules were provided to last till the next hospital visit. The mothers were seen by the research midwife at the 28-32 week visit and again on the dav after delivery. At each visit information was obtained about the use of any other drugs or iron or vitamin supplementation. Compliance was assessed by the regularity with which the study capsules were taken. Those who took the supplement daily or on most davs were grouped as compliers, and the rest were regarded as non-compliers.
At the 28-32 week visit the mothers were asked to complete a seven day dietary diary. The diarv was carefully explained to each mother and she was asked to start the diary by describing all she had eaten or drunk on the dav of the interview. Though the study was designed to look at beneficial effects, we were also keen to examine adverse outcomes, so two tailed tests were used. Confidence intervals may be calculated from the data given.
Results
A total of 500 women were successfully enrolled, by chance 250 in each group. Of these, four moved out of the area and two miscarried immediately after enrolment. The remaining 494 women (246 given zinc supplementation, 248 given placebo) were therefore available for study. There were no significant differences between the zinc supplementation and placebo treated mothers in their social and biological backgrounds. They were of similar ages and had similar obstetric histories (table I) . At the time of enrolment (at booking) there were no differences in maternal weights, blood pressure measurements, or haemoglobin, ferritin, or leucocyte zinc concentrations. The proportion of mothers who were smoking was similar, as was the prevalence of a history of nausea or vomiting and of urinary infection.
At the subsequent visit (between 28 and 32 weeks' gestation) there were no significant differences between the two groups of mothers. There was a suggestion, however, that the mothers receiving the zinc supplement had lower zinc concentrations (p=0 06) than the controls (table II) . Of the 494 mothers, 375 (76%) completed a seven day dietary diary, 347 giving details for the whole seven days. There was no difference in nutrient intake between the groups (table III) . In particular, there was no difference in mean zinc intake, which was only half the recommended intake (20 mg) for pregnant mothers. Dietary items known to reduce the absorption of zinc, such as alcohol, iron, total fibre (and cereal fibre), were consumed in equal amounts in the two groups.
By the time the mothers were delivered similar numbers had taken iron supplements, and 'among women who had taken these supplements similar proportions claimed to have taken the iron at a different time of day from the zinc (83 of 93 women given the active supplement, 65 of 82 given placebo; NS). Compliance
OUTCOME MEASURES
Complications of pregnancy-There were no significant differences in complications of pregnancy between the two groups. The mothers given zinc supplementation had similar weights, weight gains, and blood pressures, but there was a suggestion of more proteinuric hypertension in this group (11/241 mothers) than in the controls (3/238) (p=0 06). The incidence of proteinuric hypertension in the Bristol area is of the order of 3-4%. Hence the rate among the mothers receiving zinc (4 6%) was that expected, whereas that among the controls (1 3%) was less than expected.
Labour and delivery-There was no difference between the groups in any aspect of labour or delivery (table IV) . In particular, mothers receiving zinc supplements were not less likely to deliver before term or to have premature rupture of the membranes, abnormal labour, postpartum haemorrhage, or postpartum infection.
Fetuses and neonates-Two twin pregnancies occurred in the zinc treated group and one in the 
COMPLIANCE
The same measures of outcome were compared among compliers only. As in the whole series there were no differences at all. Similarly there was no significant difference between compliers and noncompliers apart from a significantly lower risk of postpartum infection among the compliers. When the compliers were compared with non-compliers within each supplementation group there was nothing of note.
Discussion
Given the extensive role of zinc in many enzymes and the well documented adverse effects of zinc deficiency in pregnant animals, its role in human pregnancy would also be expected to be wide. This study therefore examined a large number of clinically relevant variables.
The recommended daily intake of zinc during pregnancy is 20 
